Cyclacel Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Cyclacel Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 9, 2024 was 1.97M shares, a 84.4% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.97M -10.7M -84.4% Aug 9, 2024 10-Q 2024-08-14
Q1 2024 1.32M -11.2M -89.5% Mar 15, 2024 10-K 2024-03-21
Q3 2023 12.6M +104K +0.83% Nov 9, 2023 10-Q 2023-11-29
Q2 2023 12.6M +104K +0.83% Aug 9, 2023 10-Q 2023-08-10
Q1 2023 12.5M +2.55M +25.5% Mar 6, 2023 10-K/A 2023-11-29
Q3 2022 12.5M +2.56M +25.7% Nov 7, 2022 10-Q 2022-11-10
Q2 2022 12.5M +3.31M +35.8% Aug 10, 2022 10-Q/A 2022-08-16
Q1 2022 9.99M +2.89M +40.7% Mar 24, 2022 10-K 2022-03-30
Q3 2021 9.98M +5.11M +105% Nov 10, 2021 10-Q 2021-11-12
Q2 2021 9.23M +4.37M +89.8% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 7.1M -10.1M -58.7% Feb 24, 2021 10-K 2021-03-01
Q3 2020 4.86M -12.3M -71.7% Nov 11, 2020 10-Q 2020-11-12
Q2 2020 4.86M -12.3M -71.7% Aug 12, 2020 10-Q 2020-08-13
Q1 2020 17.2M 0 0% Mar 4, 2020 10-K 2020-03-05
Q3 2019 17.2M +4.7M +37.6% Nov 13, 2019 10-Q 2019-11-13
Q2 2019 17.2M +5.2M +43.4% Aug 9, 2019 10-Q 2019-08-13
Q1 2019 17.2M +5.2M +43.4% Mar 28, 2019 10-K 2019-03-28
Q3 2018 12.5M +593K +4.98% Nov 9, 2018 10-Q 2018-11-13
Q2 2018 12M +597K +5.24% Aug 9, 2018 10-Q 2018-08-09
Q1 2018 12M +7.73M +181% Mar 27, 2018 10-K 2018-03-30
Q3 2017 11.9M +7.65M +180% Nov 13, 2017 10-Q 2017-11-13
Q2 2017 11.4M +8.28M +266% Aug 8, 2017 10-Q 2017-08-10
Q1 2017 4.27M -31.3M -88% Mar 24, 2017 10-K 2017-03-31
Q3 2016 4.25M -30.5M -87.8% Nov 14, 2016 10-Q 2016-11-14
Q2 2016 3.12M -31.6M -91% Aug 9, 2016 10-Q 2016-08-11
Q1 2016 35.6M +1.19M +3.47% Mar 25, 2016 10-K 2016-03-29
Q3 2015 34.7M +11.7M +51% Nov 11, 2015 10-Q 2015-11-12
Q2 2015 34.7M +12M +53% Aug 11, 2015 10-Q 2015-08-12
Q1 2015 34.4M +14.6M +73.5% Mar 27, 2015 10-K 2015-03-31
Q3 2014 23M +4.28M +22.9% Nov 11, 2014 10-Q 2014-11-12
Q2 2014 22.7M +4.96M +28% Aug 11, 2014 10-Q 2014-08-12
Q1 2014 19.8M +8.99M +83% Mar 24, 2014 10-K 2014-03-26
Q3 2013 18.7M +10.3M +122% Nov 13, 2013 10-Q 2013-11-14
Q2 2013 17.7M -41.3M -70% Aug 13, 2013 10-Q 2013-08-14
Q1 2013 10.8M -48.2M -81.6% Mar 29, 2013 10-K 2013-04-01
Q3 2012 8.43M -45.8M -84.4% Nov 14, 2012 10-Q 2012-11-16
Q2 2012 59M +4.78M +8.82% Aug 13, 2012 10-Q 2012-08-14
Q1 2012 59M Mar 29, 2012 10-K 2012-03-30
Q3 2011 54.2M Nov 14, 2011 10-Q 2011-11-14
Q2 2011 54.2M Jun 30, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.